Having previously shown that prenatal treatment with neuroprotective peptides prevents alcohol-induced fetal anomalies and learning deficits during embryonic development, new research demonstrates how they do so using a model of pregnant mice.
Having previously shown that prenatal treatment with neuroprotective peptides NAP+SAL prevents alcohol-induced fetal anomalies and learning deficits during embryonic development, researchers from the National Institutes of Health and Columbia University attempted to demonstrate how they do so using a model of pregnant mice.
Knowing that brain-derived neurotrophic factor (BDNF) is essential to normal neuronal development and survival as well as to synaptic plasticity, Maddalena Incerti, MD, and colleagues decided to look at whether NAP+SAL's neuroprotective effects are mediated by preventing alcohol-induced changes in BDNF expression.
To do so, they treated pregnant mice on day 8 with alcohol (0.03 mL/g), placebo, or alcohol and peptides (20 g, 30 minutes before alcohol). They then harvested embryos at 6 hours, 24 hours, and day 10.
Incerti M, Vink J, Benassou I, Roberson R, Abebe D, Spong C. Prevention of the alcohol-induced changes in brain-derived neurotrophic factor expression using neuroprotective peptides in a model of fetal alcohol syndrome [abstract]. Am J Obstet Gynecol. 2009;201(6 suppl):S31. Abstract 54.
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Trimethoprim–sulfamethoxazole not found to increase infant birth weight in HIV cases
July 9th 2025A recent randomized trial found no significant improvement in birth weight or key birth outcomes from antenatal trimethoprim–sulfamethoxazole prophylaxis in human immunodeficiency virus-positive pregnant women.
Read More